文献速递糖尿病肥胖与代谢综合征

智能手机应用联合间歇扫描式持续葡萄糖监测对2型糖尿病高危人群的生活方式干预:随机试验

Lifestyle Intervention With Smartphone App and isCGM for People at High Risk of Type 2 Diabetes: Randomized Trial.
PubMed 文献 · J Clin Endocrinol Metab · 2024-01-01

本研究为12周随机非盲试验,纳入HbA1c 5.6%–6.4%或空腹血糖110–125 mg/dL且BMI>23且<40 kg/m2的2型糖尿病高危人群168例,随机分为App干预组82例和对照组86例。结果显示App组血糖70–140 mg/dL目标范围内时间较对照组显著改善(-2.6分钟/天 vs +31.5分钟/天,P=.03),BMI降低(-0.26 vs -0.59,P=.017)。结论认为该干预改善了血糖控制并伴随碳水化合物摄入减少和体重下降,需进一步试验确认能否减少2型糖尿病发病。

要点

  • App组血糖70–140 mg/dL目标范围内时间变化为-2.6分钟/天,对照组为+31.5分钟/天,P=.03。
  • App组BMI变化为-0.26,对照组为-0.59,P=.017。
  • App组血糖<70 mg/dL低于目标范围时间变化为+23.5分钟/天,对照组为-8.9分钟/天,P=.02。

核心结论

  • 智能手机应用联合间歇扫描式持续葡萄糖监测的干预改善了血糖控制,并伴随碳水化合物摄入减少和体重下降。
  • 需进一步试验确认这些干预能否减少2型糖尿病发病。

研究设计与样本

  • 12周随机非盲试验,离线招募。
  • 纳入标准为血红蛋白A1c 5.6%至6.4%或空腹血糖110至125 mg/dL,且BMI>23 kg/m2但<40 kg/m2。
  • 168例参与者随机分为干预组(App组)82例和对照组(C组)86例;平均年龄48.1岁,平均BMI 26.6 kg/m2,男性80.4%。
  • 主要终点为两组研究前后血糖70–140 mg/dL(3.9–7.8 mmol/L)目标范围内时间的变化差异。

主要发现

  • 12周后,App组血糖70–140 mg/dL目标范围内时间较C组显著改善(-2.6分钟/天 vs +31.5分钟/天,P=.03)。
  • 高于目标范围时间的变化两组无差异。
  • App组血糖<70 mg/dL低于目标范围时间改善(+23.5分钟/天 vs -8.9分钟/天,P=.02)。
  • App组BMI降低(-0.26 vs -0.59,P=.017)。

局限性

  • 原文结论指出需进一步试验确认这些干预能否减少2型糖尿病发病。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Although conventional interventions for people at high risk of developing type 2 diabetes are usually conducted face-to-face, such interventions are burdensome for health care providers. We developed a lifestyle intervention program combining lifestyle coaching via a smartphone application augmented by intermittently scanned continuous glucose monitoring without burdening health care providers. Its effectiveness for glycemic control and body weight reduction in people at risk of type 2 diabetes was investigated. MATERIALS AND METHODS: For this 12-week randomized unblinded trial with offline recruitment, participants with a hemoglobin A1c level of 5.6% to 6.4% or a fasting blood glucose of 110 to 125 mg/dL and body mass index (BMI) >23 kg/m2 but <40 kg/m2 were randomly assigned to the intervention group (App) and control group (C). The primary endpoint was the difference in time in range of blood glucose between 70 and 140 mg/dL (3.9-7.8 mmol/L) before and after the study period between the 2 groups. RESULTS: Among 168 patients (mean age, 48.1 years; mean BMI, 26.6 kg/m2; and male, 80.4%), 82 and 86 were assigned to the App group and C group, respectively. After 12 weeks, time in range of blood glucose at 70 to 140 mg/dL significantly improved in the App group compared with the C group (-2.6 minutes/day vs +31.5 minutes/day, P = .03). Changes in time above range did not differ, whereas time below range (blood glucose <70 mg/dL; +23.5 minutes/day vs -8.9 minutes/day, P = .02) improved in the App group. BMI (-0.26 vs -0.59, P = .017) was reduced in the App group compared with the C group. CONCLUSION: Intervention with a smartphone app and intermittently scanned continuous glucose monitoring increased glycemic control accompanied by decreased carbohydrate intake and weight loss. Further trials are needed to confirm whether these interventions can reduce incident type 2 diabetes.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Kitazawa M, Takeda Y, Hatta M, et al. Lifestyle Intervention With Smartphone App and isCGM for People at High Risk of Type 2 Diabetes: Randomized Trial. J Clin Endocrinol Metab. 2024. PMID: 37931069. doi:10.1210/clinem/dgad639

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。